Innova {R4HCR} | R Documentation |
Rapid Antigen Detection for SARS-CoV-2 by Lateral Flow Assay.
Description
The number of false positives in negative samples in each evaluation stage of the Innova lateral flow device.
Usage
Innova
Format
A data frame with 8 observations on the following 3 variables.
phase
Evalution phase
fp
Number of false positives
total
Total number of tests conducted
Details
The Innova LFD was a first-generation Lateral Flow Device (LFD) for rapid point-of-care (POC) SARS-CoV-2 testing. Peto at al conducted a phased evaluation of available SARS-CoV-2 antigen LFDs from 15th August to December 2020 and reported the diagnostic performance of the Innova LFD.
References
Peto, T., Affron, D., Afrough, B., Agasu, A., Ainsworth, M., Allanson, A., Allen, K., Allen, C., Archer, L., Ashbridge, N. and Aurfan, I., 2021. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. EClinicalMedicine, 36.
Examples
require(meta)
data(Innova, package = "R4HCR")
# Meta-analysis of false-positive fraction
ma1 <- metaprop(event = fp,
n = total,
studlab = phase,
backtransf=TRUE,
data = Innova)